Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Dusa reacquires rights to Levulan PDT

Sep. 5, 2002

Elidel receives positive health authority decision in 13 European countries

Aug. 21, 2002

Selective procollagen C-proteinase inhibitors presented by Pfizer

Aug. 21, 2002

Skin permeation of miconazole is enhanced by hydrogenated soybean lecithin and DDAIP formulations

Aug. 21, 2002

Periostat enters phase III trial for the treatment of rosacea

Aug. 21, 2002

Serono and Genentech sign marketing agreement for Raptiva, formerly Xanelim

Aug. 9, 2002

Inamed acquires rights to botulinum toxin type A

Aug. 8, 2002

Modex advances Allox through early-stage clinical testing

Aug. 7, 2002

Potential use of efalizumab in the treatment of T-cell-mediated diseases

Aug. 6, 2002

GRP promotes keratinocyte proliferation and wound healing in vitro and in vivo

Aug. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...